NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

WINDLAS BIOTECH LTD.

NSE : WINDLASBSE : 543329ISIN CODE : INE0H5O01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE552.200.3 (+0.05 %)
PREV CLOSE ( ) 551.90
OPEN PRICE ( ) 559.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3997
TODAY'S LOW / HIGH ( )547.65 568.65
52 WK LOW / HIGH ( )250.1 590
NSE550.65-2.1 (-0.38 %)
PREV CLOSE( ) 552.75
OPEN PRICE ( ) 547.00
BID PRICE (QTY) 550.65 (163)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 106165
TODAY'S LOW / HIGH( ) 544.05 570.90
52 WK LOW / HIGH ( )251 590.85
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 19-02 2001
Management Info
Vivek Dhariwal - Chairman Hitesh Windlass - Managing Director
Registered Office

Address 40 / 1,Mohabewala Industrial Area,,
Dehradun,
Uttarakhand-248110

Phone 0135-6608000-30

Email grievance@windlasbiotech.com

Website www.windlasbiotech.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
29Apr Windlas Biotech informs about analyst
Pursuant to the relevant provisions of SEBI (Listing Obligations and Dis..
03Apr Windlas Biotech surges on commissionin
Windlas Biotech is currently trading at Rs. 562.85, up by 12.90 points o..
02Apr Windlas Biotech informs about press re
Windlas Biotech has informed that it attached press release on ‘Windlas..
02Apr Windlas Biotech commissions injectable
Windlas Biotech has commissioned its state-of-the-art injectable facilit..
20Feb Windlas Biotech informs about analyst
Pursuant to the relevant provisions of SEBI (Listing Obligations and Dis..
MORE
Financials
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit150.98426.44
Gross Profit 198.07 570.57
Operating Profit 235.01702.07
Net Sales 1622.135130.83
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 8679.45 (4.27%)
M.Cap (Rs. in Cr)19989.31
Abbott India (BSE)
 26604.35 (0.71%)
M.Cap (Rs. in Cr)56416.90
Amrutanjan Healthcar (BSE)
 786.60 (12.70%)
M.Cap (Rs. in Cr)2274.11
NGL Fine-Chem (BSE)
 2634.60 (3.41%)
M.Cap (Rs. in Cr)1612.46
Dr. Reddy's Lab (BSE)
 6288.30 (1.34%)
M.Cap (Rs. in Cr)104428.23
MORE
Shareholding Pattern
PROMOTERS 62.82%
NON-INSTITUTION 24.19%
MUTUAL FUNDS/UTI 10.37%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| REFUND & CANCELLATION POLICY| DISCLAIMER| DISCLOSURE| KMP DETAILS | CDSL e-Voting | SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016|SEBI-PMS: INP000007100|LEI- 3358007DLCFNHY8J2F96

Filing compliant on SCORES – Easy & quick

  • Register on SCORES portal
  • Mandatory details for filing complaints on SCORES:
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • Benefits:
    • i.) Effective communication
    • ii.) Speedy redressal of the grievances
SMART ODR Portal
INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Copyright © 2021 NNM Securities.com

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.